Her primary areas of investigation include Internal medicine, Dementia, Alzheimer's disease, Neurology and Pathology. She combines subjects such as Endocrinology and Surgery with her study of Internal medicine. She works in the field of Dementia, focusing on Dementia with Lewy bodies in particular.
Her Dementia with Lewy bodies research includes elements of Lewy body and Psychiatry. The study incorporates disciplines such as Gastroenterology, Tau protein and Cerebrospinal fluid in addition to Neurology. Her Odds ratio research integrates issues from Relative risk, Alzheimer's disease biomarkers, Retrospective cohort study and Hazard ratio.
Elisabet Londos mainly focuses on Dementia, Internal medicine, Neurology, Dementia with Lewy bodies and Disease. Dementia is a subfield of Pathology that Elisabet Londos studies. Her research on Internal medicine also deals with topics like
Her Neurology research is multidisciplinary, relying on both Cognition, Proportional hazards model, Alzheimer's disease, Physical therapy and Pediatrics. Her Dementia with Lewy bodies research focuses on Memantine and how it relates to Episodic memory. Her Disease study combines topics in areas such as Observational study, Cholinesterase, Confidence interval, Life expectancy and Concomitant.
Her scientific interests lie mostly in Dementia with Lewy bodies, Dementia, Disease, Internal medicine and Neurology. Her Dementia with Lewy bodies research is within the category of Pathology. Her Dementia study incorporates themes from Psychiatry and Geriatrics.
Elisabet Londos has researched Disease in several fields, including Observational study, Oncology and Confidence interval. Her research in Internal medicine intersects with topics in Cognition and Activities of daily living. She interconnects Wakefulness and Lewy body disease in the investigation of issues within Neurology.
Elisabet Londos mostly deals with Dementia with Lewy bodies, Internal medicine, Dementia, Medical genetics and Genome-wide association study. Her biological study spans a wide range of topics, including Dysphagia, Genetics, Frontotemporal dementia and Cohort. Her work in Internal medicine is not limited to one particular discipline; it also encompasses Gastroenterology.
The Gastroenterology study combines topics in areas such as Biomarker, Alzheimer's disease, Pittsburgh compound B, REM sleep behavior disorder and Rasagiline. Her Dementia study integrates concerns from other disciplines, such as Interquartile range, Surgery, Swallowing, Parkinson's disease and Neurology. As part of one scientific family, Elisabet Londos deals mainly with the area of Medical genetics, narrowing it down to issues related to the Disease, and often Odds ratio, Oncology, Psychosis and Etiology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium
I. G. McKeith;I. G. McKeith;D. W. Dickson;J. Lowe;M. Emre.
Neurology (2005)
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
Oskar Hansson;Oskar Hansson;Henrik Zetterberg;Peder Buchhave;Peder Buchhave;Elisabet Londos;Elisabet Londos.
Lancet Neurology (2006)
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
Dag Aarsland;Dag Aarsland;Clive Ballard;Zuzana Walker;Zuzana Walker;Fredrik Bostrom.
Lancet Neurology (2009)
Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
Sara Hall;Annika Öhrfelt;Radu Constantinescu;Ulf Andreasson.
JAMA Neurology (2012)
Prediction of Alzheimer's Disease Using the CSF Abeta42/Abeta40 Ratio in Patients with Mild Cognitive Impairment.
Oskar Hansson;Henrik Zetterberg;Peder Buchhave;Ulf Andreasson.
Dementia and Geriatric Cognitive Disorders (2007)
Evaluation of plasma A beta(40) and A beta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment
Oskar Hansson;Oskar Hansson;Henrik Zetterberg;Eugeen Vanmechelen;Hugo Vanderstichele.
Neurobiology of Aging (2010)
Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease
Henrik Zetterberg;Ulf Andreasson;Oskar Hansson;Guoxin Wu.
JAMA Neurology (2008)
Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer's disease
Lars Gerhardsson;Thomas Lundh;Lennart Minthon;Elisabet Londos.
Dementia and Geriatric Cognitive Disorders (2008)
CSF biomarkers predict a more malignant outcome in Alzheimer disease.
A K Wallin;Kristina Blennow;H Zetterberg;Elisabet Londos.
Neurology (2010)
Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of Dementia with Lewy Bodies.
Jose Bras;Rita Guerreiro;Lee Darwent;Laura Parkkinen.
Human Molecular Genetics (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Lund University
Lund University
University of Gothenburg
King's College London
University of Gothenburg
University of Exeter
University of Sydney
University of Cambridge
Lund University
University of California, San Diego
Stony Brook University
University of Auckland
Max Planck Society
Lund University
University of Washington
National Institutes of Health
Agricultural Research Service
University of Chicago
Rega Institute for Medical Research
University of British Columbia
Grenoble Alpes University
East China Normal University
Grenoble Alpes University
Bowling Green State University
University of Bristol
University of Kent